US FDA suspends Kezar Life Sciences lupus treatment trial after patient deaths By Reuters by Technical Terrence Team 10/04/2024 0 (Reuters) -The US Food and Drug Administration has clinically suspended Kezar Life Sciences (NASDAQ:)' trial of an experimental lupus drug, ...